Therapeutic Potential of Glycolipid Ligands for Natural Killer (NK) T Cells in the Suppression of Autoimmune Diseases

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 3, 2005-09 ,pp. : 315-322

Bentham Science Publishers

Access to resources Recommend Favorite

mTOR Signaling and Metabolic Regulation of T Cells: New Potential Therapeutic Targets in Autoimmune Diseases

By  

Current Pharmaceutical Design, Vol. 17, Iss. 35, 2011-12 ,pp. : 3888-3897

Bentham Science Publishers

Access to resources Recommend Favorite

Natural and Induced Regulatory T Cells: Targets for Immunotherapy of Autoimmune Disease and Allergy

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 3, 2006-09 ,pp. : 141-148

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroinflammation in Prion Diseases: Concepts and Targets for Therapeutic Intervention

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 5, 2009-01 ,pp. : 329-341

Bentham Science Publishers

Access to resources Recommend Favorite

Are B Cells a Potential Target for Therapeutic Intervention in the Classical T Cell-Mediated Autoimmune Disease Type 1 Diabetes?

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 2, 2009-06 ,pp. : 130-138

Bentham Science Publishers

Access to resources Recommend Favorite